circRNA-miRNA Complex Participates in the Apoptosis of Myocardial Cells in Myocardial Ischemia/Reperfusion Injury

Yu Sun1, Yuanmei Zhang2, Zebing Ye1

  • 1Department of Cardiac Intensive Care Unit, Cardiovascular Hospital, Guangdong Second Provincial General Hospital, Guangzhou, Guangdong, 510310, China.

Discovery Medicine
|July 26, 2022
PubMed

Insights

This study reveals that circ_Ddx60 protects against myocardial ischemia/reperfusion (I/R) injury by inhibiting cardiac cell apoptosis. It achieves this by regulating the miR-302a-3p/Bcl2a1a axis, offering new therapeutic insights.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • RNA Biology

Background:

  • Myocardial ischemia/reperfusion (I/R) injury is a significant clinical challenge.
  • Understanding the molecular mechanisms underlying I/R injury is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role and mechanism of circular RNA Ddx60 (circ_Ddx60) in a mouse model of myocardial I/R injury.
  • To explore the regulatory pathway involving circ_Ddx60, miR-302a-3p, and Bcl2a1a in cardiac cells.

Main Methods:

  • RNA sequencing and bioinformatics analysis to identify differentially expressed circRNAs and mRNAs.
  • Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) for gene expression validation.
  • Cellular assays to assess apoptosis and protein expression in HL-1 cells under hypoxia/reoxygenation (H/R).

Main Results:

  • circ_Ddx60 was identified as differentially expressed in I/R injury and was upregulated in HL-1 cells under H/R conditions.
  • Overexpression of circ_Ddx60 inhibited apoptosis and promoted Bcl2a1a expression in cardiac cells.
  • circ_Ddx60 directly targets miR-302a-3p, and this interaction mediates the regulation of apoptosis and Bcl2a1a expression.

Conclusions:

  • circ_Ddx60 plays a protective role in myocardial I/R injury by inhibiting apoptosis.
  • The mechanism involves circ_Ddx60 regulating the miR-302a-3p/Bcl2a1a axis.
  • This finding offers novel therapeutic targets for preventing myocardial I/R injury.